Candel Therapeutics, Inc.
SEC CIK 1841387 · CADL · last insider filing 2026-06-24
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Papa Joseph C | Director | filed 2022 - 2026 |
| Manning Paul B | Director | filed 2021 - 2026 |
| Benz Edward J. JR | Director | filed 2021 - 2026 |
| Gaeta Renee | Director | filed 2022 - 2026 |
| Nguyen Diem | Director | filed 2021 - 2026 |
| Nabel Gary J. | Director | filed 2022 - 2026 |
| Martell Christopher | Director | filed 2021 - 2026 |
| Loggia Nicoletta | Director | filed 2023 - 2026 |
| Radhakrishnan Maha | Director | filed 2025 - 2026 |
| Tak Paul Peter | Director · President & CEO | filed 2021 - 2026 |
| Aguilar-Cordova Estuardo | Director · Chief Scientific Officer | filed 2021 - 2025 |
| Smith Alan E | Director | filed 2021 - 2021 |
| Gandhi Shaan-Chirag C | Director | filed 2021 - 2021 |
| Meirav Udi | Director | filed 2021 - 2021 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Nichols William Garrett | Chief Medical Officer | filed 2022 - 2026 |
| Barone Francesca | Chief Scientific Officer | filed 2022 - 2026 |
| Tyagarajan Seshu | See Remarks | filed 2022 - 2026 |
| Schoch Charles | See Remarks | filed 2024 - 2026 |
| Aguilar Laura K. | Chief Medical Officer | filed 2021 - 2025 |
| Amello Jason | Chief Financial Officer | filed 2022 - 2023 |
| Stewart Susan B. | Chief Regulatory Officer | filed 2021 - 2022 |
| Canepa John J | Chief Financial Officer | filed 2021 - 2022 |
| Caffo Nathan | Chief Business Officer | filed 2021 - 2021 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.